Search Results 671-680 of 14705 for استخدام حبوب منع الحمل

  1. ASCENT-Study Of Sacituzumab Govitecan In Refractory/Relapsed Triple-Negative Breast Cancer - Mayo Clinic

    Women who are pregnant or lactating. ... prevent completion of study procedures and follow ... Any use of this site constitutes your agreement to the Terms and ...

  2. A Study Evaluating The Safety, Efficacy, And Pharmacokinetics Of Mosunetuzumab And A Combined Regimen Of Mosunetuzumab And Venetoclax In Participants With Relapsed Or Refractory Chronic Lymphocytic Leukemia - Mayo Clinic

    * Pregnant or breastfeeding, or intending to become pregnant ... * Inability to swallow a large number of tablets * ... Any use of this site constitutes your ...

  3. (VOYAGER) Study Of Avapritinib Vs Regorafenib In Patients With Locally Advanced Unresectable Or Metastatic GIST - Mayo Clinic

    About this study. This is an open-label, randomized, Phase 3 study in patients with locally advanced unresectable or metastatic GIST (advanced GIST) of ...

  4. Phase 2 Study To Evaluate The Oral Combination Of Ixazomib (MLN9708) With Cyclophosphamide And Dexamethasone In Patients With Newly Diagnosed Or Relapsed And/or Refractory Multiple Myeloma - Mayo Clinic

    adhere to any treatment-specific pregnancy prevention guidelines for cyclophosphamide and dexamethasone. ... Any use of this site constitutes your ...

  5. A Study To Evaluate The Safety And Tolerability Of TreT In Subjects With PAH Currently Using Tyvaso - Mayo Clinic

    Subject is pregnant or lactating. Subject has ... Subject has used any investigational drug ... Any use of this site constitutes your agreement ...

  6. An Investigational Immuno-therapy Study Of Nivolumab, Compared To Placebo, In Patients With Bladder Or Upper Urinary Tract Cancer, Following Surgery To Remove The Cancer - Mayo Clinic

    ... pregnancy prevention and the implications of an unexpected pregnancy. ... Any use of this site constitutes your agreement to the Terms and Conditions and ...

  7. Wild-Type Reovirus In Combination With Sargramostim In Treating Younger Patients With High-Grade Relapsed Or Refractory Brain Tumors - Mayo Clinic

    Skip to site navigation. Skip to ... Fetal and newborn toxicity: any of the following. Pregnant women ... Any use of this site constitutes your agreement ...

  8. Study Of The Safety, Tolerability, Pharmacokinetics And Biomarker Of DONQ52 In Celiac Disease Patients - Mayo Clinic

    Furthermore, to characterize the DONQ52 PK profile following single and multiple subcutaneous (SC) dose(s) in celiac disease patients and to investigate the ...

  9. A Phase 1 Dose Escalation And Expansion Study Of TGR-1202 + Ruxolitinib In Subjects With Primary Myelofibrosis (PMF), Post-Polycythemia Vera MF (PPV-MF), Post-Essential Thrombocythemia MF (PET-MF), MDS/MPN, Or Polycythemia Vera Resistant To Hydroxyurea - Mayo Clinic

    ... pregnancy test within 72 hours prior to the first ... Any serious, unstable medical or psychiatric condition that would prevent ... Any use of this site constitutes ...

  10. A Study Of Patient-Reported Outcome Instrument For Glucocorticoid Withdrawal Syndrome - Mayo Clinic

    Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices. Medical records research — uses historical ...